APA (7th ed.) Citation

MB, M., VM, C., EMS, C., JM, B. d. M., FSR, I., N, C. S., . . . WR, P. (2023). Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer. Antioxidants (Basel, Switzerland), 12(3), . https://doi.org/10.3390/antiox12030586

Chicago Style (17th ed.) Citation

MB, Madureira, et al. "Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer." Antioxidants (Basel, Switzerland) 12, no. 3 (2023). https://doi.org/10.3390/antiox12030586.

MLA (9th ed.) Citation

MB, Madureira, et al. "Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer." Antioxidants (Basel, Switzerland), vol. 12, no. 3, 2023, https://doi.org/10.3390/antiox12030586.